Flt3 in regulation of type I interferon-producing cell and dendritic cell development

Annals of the New York Academy of Sciences

Volumn 1106, Issue , 2007, Pages 253-261

  Onai, Nobuyuki ^a,b   Obata Onai, Aya ^a,b   Schmid, Michael A ^a   Manz, Markus G ^a,c  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Dendritic cells; Flt3; Hematopoiesis

Indexed keywords

CYTOKINE; FLT3 LIGAND; INTERFERON; FLT3 LIGAND PROTEIN; LIGAND; MEMBRANE PROTEIN; ONCOPROTEIN; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

BONE MARROW CELL; CELL ACTIVITY; CELL DEGENERATION; CELL DIFFERENTIATION; CELL MATURATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME REGULATION; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; IN VIVO STUDY; LYMPHOID CELL; NONHUMAN; PLASMA CELL; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; CELL LINEAGE; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALIA;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; DENDRITIC CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEMATOPOIETIC STEM CELLS; HUMANS; INTERFERON TYPE I; LIGANDS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; UP-REGULATION;

EID: 34548453209     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1392.015     Document Type: Conference Paper

References (48)

1. KONDO, M. et al. 2003. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21: 759-806.
2. METCALF, D. 1998. Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation. Blood. 92: 345-347; discussion 352.
3. CANTOR, A.B. & S.H. ORKIN. 2001. Hematopoietic development: a balancing act. Curr. Opin. Genet. Dev. 11: 513-519.
4. AKASHI, K. et al. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404: 193-197.
5. MANZ, M. G. et al. 2002. Prospective isolation of human clonogenic common myeloid progenitors. Proc. Natl. Acad. Sci. USA 99: 11872-11877.
6. GALY, A. et al. 1995. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3: 459-473.
7. KONDO, M., I. L. WEISSMAN & K. AKASHI. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661-672.
8. ORKIN, S. H. 2000. Diversification of haematopoietic stem cells to specific lineages. Nat. Rev. Genet. 1: 57-64.
9. AKASHI, K. et al. 2003. Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood 101: 383-389.
10. NUTT, S. L. et al. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5 [see comments]. Nature 401: 556-562.
11. ROLINK, A. G. et al. 1999. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 401: 603-606.
12. IWASAKI, H. et al. 2003. GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages. Immunity 19: 451-462.
13. XIE, H. et al. 2004. Stepwise reprogramming of B cells into macrophages. Cell 117: 663-676.
14. KONDO, M. et al. 2000. Cell fate conversion of lymphoid committed progenitors by instructive actions of cytokines. Nature 407: 383-386.
15. KING, A. G. et al. 2002. Lineage infidelity in myeloid cells with TCR gene rearrangement: a latent developmental potential of proT cells revealed by ectopic cytokine receptor signaling. Proc. Natl. Acad. Sci. USA 99: 4508-4513.
16. IWASAKI-ARAI, J. et al. 2003. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion. J. Exp. Med. 197: 1311-1322.
17. BANCHEREAU, J. & R. M. STEINMAN. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
18. LANZAVECCHIA, A. & F. SALLUSTO. 2001. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 13: 291-298.
19. STEINMAN, R. M., D. HAWIGER & M. C. NUSSENZWEIG. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
20. SHORTMAN, K. & Y. J. LIU. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2: 151-161.
21. TRAVER, D. et al. 2000. Development of CD8alpha-positive dendritic cells from a common myeloid progenitor [In Process Citation]. Science 290: 2152-2154.
22. MANZ, M. G. et al. 2001. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 97: 3333-3341.
23. WU, L. et al. 2001. Development of thymic and splenic dendritic cell populations from different hemopoietic precursors. Blood. 98: 3376-3382.
24. SHIGEMATSU, H. et al. 2004. Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity 21: 43-53.
25. CHICHA, L.,D. JARROSSAY & M. G. MANZ. 2004. Clonal type I interferon-producing and dendritic cell precursors are contained in both human lymphoid and myeloid progenitor populations. J. Exp. Med. 200: 1519-1524.
26. KARSUNKY, H. et al. 2005. Developmental origin of interferon-alpha-producing dendritic cells from hematopoietic precursors. Exp. Hematol. 33: 173-181.
27. LYMAN, S. D. & S. E. Jacobsen. 1998. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 91: 1101-1134.
28. MCKENNA, H. J. et al. 2000. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95: 3489-3497.
29. LAOUAR, Y. et al. 2003. STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 19: 903-912.
30. TUSSIWAND, R. et al. 2005. Inhibition of natural type I IFN-producing and dendritic cell development by a small molecule receptor tyrosine kinase inhibitor with Flt3 affinity. J. Immunol. 175: 3674-3680.
31. MARASKOVSKY, E. et al. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184: 1953-1962.
32. KARSUNKY, H. et al. 2003. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J. Exp. Med. 198: 305-313.
33. MILLER, G. et al. 2003. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties. J. Immunol. 170: 3554-3564.
34. GILLIET, M. et al. 2002. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195: 953-958.
35. ADOLFSSON, J. et al. 2001. Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15: 659-669.
36. CHRISTENSEN, J. L. & I. L. WEISSMAN. 2001. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA 98: 14541-14546.
37. D'AMICO, A. & L. WU. 2003. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J. Exp. Med. 198: 293-303.
38. MENDE, I. et al. 2006. Flk2+ myeloid progenitors are the main source of Langerhans cells. Blood 107: 1383-1390.
39. ONAI, N. et al. 2006. Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development. J. Exp. Med. 203: 227-238.
40. MIZUKI, M. et al. 2003. Suppression ofmyeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations. Blood 101: 3164-3173.
41. FRIEDMAN, A. D. 2002. Transcriptional regulation of granulocyte and monocyte development. Oncogene 21: 3377-3390.
42. ANDERSON, K. L. et al. 2000. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J. Immunol. 164: 1855-1861.
43. GUERRIERO, A. et al. 2000. PU.1 is required formyeloid-derived but not lymphoidderived dendritic cells. Blood 95: 879-885.
44. MIYAMOTO, T. et al. 2002. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev. Cell 3: 137-147.
45. ZHANG, P. et al. 2000. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 96: 2641-2648.
46. NERLOV, C. et al. 2000. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood 95: 2543-2551.
47. EZOE, S. et al. 2005.GATA transcription factors inhibit cytokine-dependent growth and survival of a hematopoietic cell line through the inhibition of STAT3 activity. J. Biol. Chem. 280: 13163-13170.
48. KULESSA, H., J. FRAMPTON & T. GRAF. 1995. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev. 9: 1250-1262.